|Articles|October 1, 2015
- Applied Clinical Trials-10-01-2015
- Volume 24
- Issue 10
Applied Clinical Trials Digital Edition - October/November 2015
Trial Design: Gene Transfer: Key Challenges Therapy Masking Assessment Safety Reporting: Death Waivers Fall Short Subject Engagement: Phase I Satisfaction Scores Also in this issue: Informed Consent Changes in Works Europe's Embrace of New Science Alzheimer's and Patient Safety
Advertisement
Articles in this issue
almost 11 years ago
Top Investigator Lays out Strategy for Avoiding Conflictsalmost 11 years ago
Changes Ahead for Informed Consent, IRBs, Transparencyalmost 11 years ago
Europe: At Last, the Hunt is On for Trials That Fit Sciencealmost 11 years ago
Developing New Alzheimer’s Drugs With a Focus on Patient Safetyalmost 11 years ago
Inclusion/Exclusion Criteria Show Minimal Risealmost 11 years ago
A New Look at the Arsenal of Tech Solutionsalmost 11 years ago
Human Gene Transfer Studies: What Clinicians Should Knowalmost 11 years ago
Death Waivers an Incomplete Picture of Drug Safetyalmost 11 years ago
Evaluating the Effects of Therapy Maskingalmost 11 years ago
Satisfaction of Healthy Subjects in Phase I TrialsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
2
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
3
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
4
Before Burden Becomes Risk: Capturing Friction in Real Time
5